1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

08 Aug 2024
Admin
News Article

SK Pharmteco, Rznomics Collaborate for RNA-Based Gene Therapy Development and Manufacturing

SK pharmteco, Rznomics collaborate for RNA-based gene therapy development and manufacturing

Overview

SK pharmteco, a global contract development, manufacturing, and analytical testing organization, and Rznomics Inc., a South Korea-based biopharmaceutical company, have signed a memorandum of understanding (MoU) for a contract development and manufacturing partnership.

Post Partnership

When finalized, the multi-year partnership will establish a strategic collaboration between SK pharmteco and Rznomics to develop and commercialize multiple gene therapy products.
SK pharmteco will provide technical expertise and resources, including the facilities and personnel, to enable a smooth transition from clinical to full-scale commercial manufacturing of Rznomics’ innovative ribonucleic acid (RNA)-based biopharmaceuticals.

Words from CCO: SK Pharmteco

“We are thrilled about the opportunity to partner with Rznomics on their groundbreaking initiatives,” said Andy Fenny, chief commercial officer of SK pharmteco.
“By combining our significant expertise in gene therapy manufacturing with Rznomics’ innovative RNA-based therapeutic approach, we believe this collaboration has the potential to deliver life-changing treatments to patients in need quickly.”

Words from CEO: Rznomics

Seong-Wook Lee, president and chief executive officer of Rznomics, commented: “This partnership will mark late-stage development and manufacturing of our gene therapy pipeline to prepare the path towards Phase II and later stage clinical trials and potential commercialization. We look forward to working closely with SK pharmteco.”

SK Pharmteco

SK pharmteco is a global contract development and manufacturing organization (CDMO) with 13 offices and manufacturing facilities across the US, Europe, and Korea.

About Rznomics

Rznomics is a South Korea-based innovative RNA biopharmaceutical company with a vision to treat and conquer various human intractable diseases.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!